METTL25
gene geneOn this page
Also known as FLJ22789
Summary
METTL25 (methyltransferase like 25, HGNC:26228) is a protein-coding gene on chromosome 12q21.31, encoding Probable methyltransferase-like protein 25 (Q8N6Q8). Probable methyltransferase.
Predicted to enable methyltransferase activity. Predicted to be involved in methylation.
Source: NCBI Gene 84190 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 94 total
- MANE Select transcript:
NM_032230
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26228 |
| Approved symbol | METTL25 |
| Name | methyltransferase like 25 |
| Location | 12q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22789 |
| Ensembl gene | ENSG00000127720 |
| Ensembl biotype | protein_coding |
| Entrez | 84190 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 8 protein_coding, 5 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000248306, ENST00000547357, ENST00000547985, ENST00000548200, ENST00000548432, ENST00000548569, ENST00000550058, ENST00000550298, ENST00000551645, ENST00000551722, ENST00000552741, ENST00000872357, ENST00000872358, ENST00000872359, ENST00000935491
RefSeq mRNA: 3 — MANE Select: NM_032230
NM_001319675, NM_001347934, NM_032230
CCDS: CCDS9024
Canonical transcript exons
ENST00000248306 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000910621 | 82358529 | 82358824 |
| ENSE00003463804 | 82398795 | 82399394 |
| ENSE00003481514 | 82430893 | 82430987 |
| ENSE00003483236 | 82476644 | 82476718 |
| ENSE00003534997 | 82456727 | 82456820 |
| ENSE00003560476 | 82386803 | 82386967 |
| ENSE00003561003 | 82402983 | 82403130 |
| ENSE00003595422 | 82438718 | 82438791 |
| ENSE00003604653 | 82389816 | 82389922 |
| ENSE00003614876 | 82477281 | 82477352 |
| ENSE00003621319 | 82434695 | 82434724 |
| ENSE00003645472 | 82478932 | 82479239 |
Expression profiles
Bgee: expression breadth ubiquitous, 248 present calls, max score 92.41.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.6958 / max 73.8873, expressed in 1649 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127144 | 5.3494 | 1619 |
| 127145 | 0.3373 | 160 |
| 206824 | 0.0091 | 6 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| germinal epithelium of ovary | UBERON:0001304 | 92.41 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 90.82 | silver quality |
| endothelial cell | CL:0000115 | 90.21 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.78 | gold quality |
| parietal pleura | UBERON:0002400 | 88.52 | gold quality |
| tibia | UBERON:0000979 | 87.75 | gold quality |
| oviduct epithelium | UBERON:0004804 | 87.39 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.94 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 86.72 | gold quality |
| nasopharynx | UBERON:0001728 | 86.70 | gold quality |
| upper arm skin | UBERON:0004263 | 85.02 | gold quality |
| adrenal tissue | UBERON:0018303 | 84.76 | gold quality |
| corpus callosum | UBERON:0002336 | 84.59 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 84.34 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.06 | gold quality |
| cerebellar cortex | UBERON:0002129 | 83.91 | gold quality |
| oocyte | CL:0000023 | 83.79 | gold quality |
| visceral pleura | UBERON:0002401 | 83.75 | gold quality |
| sperm | CL:0000019 | 83.64 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 83.56 | gold quality |
| cerebellum | UBERON:0002037 | 83.04 | gold quality |
| metanephros | UBERON:0000081 | 82.85 | gold quality |
| colonic epithelium | UBERON:0000397 | 82.81 | gold quality |
| pituitary gland | UBERON:0000007 | 82.62 | gold quality |
| tendon | UBERON:0000043 | 82.60 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 82.45 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 82.40 | gold quality |
| adenohypophysis | UBERON:0002196 | 82.03 | gold quality |
| monocyte | CL:0000576 | 81.94 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 223.25 |
| E-ANND-3 | yes | 4.48 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting METTL25, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-5000-3P | 98.79 | 65.63 | 1251 |
| HSA-MIR-1237-3P | 98.55 | 67.65 | 1423 |
| HSA-MIR-1246 | 98.54 | 66.21 | 959 |
| HSA-MIR-4436A | 98.05 | 64.83 | 1140 |
| HSA-MIR-6787-3P | 97.75 | 66.17 | 1233 |
| HSA-MIR-4700-3P | 97.74 | 68.64 | 1014 |
| HSA-MIR-675-3P | 95.77 | 69.27 | 675 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mettl25 | ENSDARG00000045754 |
| mus_musculus | Mettl25 | ENSMUSG00000036009 |
| rattus_norvegicus | Mettl25 | ENSRNOG00000027451 |
| drosophila_melanogaster | CG2906 | FBGN0033240 |
| caenorhabditis_elegans | F25H2.12 | WBGENE00009123 |
Paralogs (1): METTL25B (ENSG00000143303)
Protein
Protein identifiers
Probable methyltransferase-like protein 25 — Q8N6Q8 (reviewed: Q8N6Q8)
All UniProt accessions (4): Q8N6Q8, F8VZA8, H0YIN2, H0YIW7
UniProt curated annotations — full annotation on UniProt →
Function. Probable methyltransferase.
RefSeq proteins (3): NP_001306604, NP_001334863, NP_115606* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025714 | Methyltranfer_dom | Domain |
| IPR029063 | SAM-dependent_MTases_sf | Homologous_superfamily |
| IPR052220 | METTL25 | Family |
Pfam: PF13679
UniProt features (5 total): sequence conflict 2, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N6Q8-F1 | 76.70 | 0.61 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 85 (showing top):
chr12q21, GOBP_METHYLATION, GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS, CEBPZ_TARGET_GENES, CHAF1B_TARGET_GENES, CIITA_TARGET_GENES, DIDO1_TARGET_GENES, FOXD2_TARGET_GENES, FOXE1_TARGET_GENES, GLI4_TARGET_GENES, HHEX_TARGET_GENES, HMG20B_TARGET_GENES, IGLV5_37_TARGET_GENES, KAT2A_TARGET_GENES, KAT5_TARGET_GENES
GO Biological Process (1): methylation (GO:0032259)
GO Molecular Function (2): methyltransferase activity (GO:0008168), transferase activity (GO:0016740)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metabolic process | 1 |
| transferase activity, transferring one-carbon groups | 1 |
| catalytic activity | 1 |
Protein interactions and networks
STRING
314 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| METTL25 | EEF1AKMT2 | Q5JPI9 | 800 |
| METTL25 | METTL8 | Q9H825 | 783 |
| METTL25 | METTL2B | Q6P1Q9 | 756 |
| METTL25 | TMT1B | Q6UX53 | 749 |
| METTL25 | METTL9 | Q9H1A3 | 734 |
| METTL25 | METTL13 | Q8N6R0 | 681 |
| METTL25 | METTL16 | Q86W50 | 624 |
| METTL25 | METTL21C | Q5VZV1 | 581 |
| METTL25 | METTL5 | Q9NRN9 | 559 |
| METTL25 | METTL24 | Q5JXM2 | 557 |
| METTL25 | METTL26 | Q96S19 | 553 |
| METTL25 | FGD6 | Q6ZV73 | 540 |
| METTL25 | METTL27 | Q8N6F8 | 537 |
| METTL25 | TMEM126A | Q9H061 | 531 |
| METTL25 | METTL2A | Q96IZ6 | 528 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RPGRIP1 | NEK4 | psi-mi:“MI:0914”(association) | 0.620 |
| METTL25 | H1-5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| METTL25 | NRDC | psi-mi:“MI:0915”(physical association) | 0.400 |
| HTR3C | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| METTL25 | NRDC | psi-mi:“MI:0914”(association) | 0.350 |
| S100B | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| HTR3C | GET1 | psi-mi:“MI:0914”(association) | 0.350 |
| NRAS | IGKV2D-24 | psi-mi:“MI:0914”(association) | 0.350 |
| METTL25 | RPGRIP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): METTL25 (Affinity Capture-MS), METTL25 (Affinity Capture-MS), NRD1 (Affinity Capture-MS), PCBP3 (Affinity Capture-MS), RPGRIP1 (Affinity Capture-MS), METTL25 (Proximity Label-MS), METTL25 (Affinity Capture-MS), METTL25 (Affinity Capture-MS), NRD1 (Affinity Capture-MS), METTL25 (Affinity Capture-MS), METTL25 (Cross-Linking-MS (XL-MS)), METTL25 (Cross-Linking-MS (XL-MS)), METTL25 (Cross-Linking-MS (XL-MS)), METTL25 (Cross-Linking-MS (XL-MS)), METTL25 (Affinity Capture-RNA)
ESM2 similar proteins: A0JM24, A1A5R7, A2AKG8, A2CI34, D3YWQ0, F1MAB7, F6S215, O08653, O43149, O54705, O62699, P29477, P35608, P59438, P97499, Q06518, Q08DB2, Q20CR4, Q27995, Q28314, Q4R856, Q4TVR5, Q4VSN2, Q4VSN3, Q4VSN4, Q4VSN5, Q5BIW4, Q5EB20, Q5R6T6, Q5SSH7, Q5TEA3, Q5VW36, Q6NV72, Q6NXH8, Q6NXP6, Q6P996, Q6XUX0, Q6XUX1, Q6XUX2, Q6XUX3
Diamond homologs: Q6NXH8, Q8N6Q8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
94 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 70 |
| Likely benign | 11 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2501 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:82358754:G:GT | donor_gain | 1.0000 |
| 12:82358806:G:GT | donor_gain | 1.0000 |
| 12:82388913:GACCA:G | donor_gain | 1.0000 |
| 12:82389805:A:AG | acceptor_gain | 1.0000 |
| 12:82389806:T:G | acceptor_gain | 1.0000 |
| 12:82389811:A:AG | acceptor_gain | 1.0000 |
| 12:82389811:ATTAG:A | acceptor_gain | 1.0000 |
| 12:82389812:T:G | acceptor_gain | 1.0000 |
| 12:82389812:TTAGG:T | acceptor_loss | 1.0000 |
| 12:82389813:TAG:T | acceptor_loss | 1.0000 |
| 12:82389814:A:AG | acceptor_gain | 1.0000 |
| 12:82389814:AG:A | acceptor_gain | 1.0000 |
| 12:82389814:AGGT:A | acceptor_gain | 1.0000 |
| 12:82389815:G:GA | acceptor_gain | 1.0000 |
| 12:82389815:GG:G | acceptor_gain | 1.0000 |
| 12:82389815:GGT:G | acceptor_gain | 1.0000 |
| 12:82389815:GGTG:G | acceptor_gain | 1.0000 |
| 12:82389815:GGTGA:G | acceptor_gain | 1.0000 |
| 12:82389918:AGCAG:A | donor_gain | 1.0000 |
| 12:82389919:GCAG:G | donor_gain | 1.0000 |
| 12:82389919:GCAGG:G | donor_gain | 1.0000 |
| 12:82389923:G:GG | donor_gain | 1.0000 |
| 12:82389924:T:A | donor_loss | 1.0000 |
| 12:82402975:T:G | acceptor_gain | 1.0000 |
| 12:82402979:AAAG:A | acceptor_gain | 1.0000 |
| 12:82402982:GGATT:G | acceptor_gain | 1.0000 |
| 12:82403067:G:GT | donor_gain | 1.0000 |
| 12:82434693:A:G | acceptor_gain | 1.0000 |
| 12:82456721:TTACA:T | acceptor_loss | 1.0000 |
| 12:82456722:TACA:T | acceptor_loss | 1.0000 |
AlphaMissense
3946 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:82438742:C:A | R477S | 0.997 |
| 12:82438749:T:A | V479D | 0.997 |
| 12:82438752:T:C | L480P | 0.997 |
| 12:82398828:A:C | S189R | 0.996 |
| 12:82398830:C:A | S189R | 0.996 |
| 12:82398830:C:G | S189R | 0.996 |
| 12:82403004:C:G | H385D | 0.996 |
| 12:82438743:G:C | R477P | 0.996 |
| 12:82478987:G:C | R592T | 0.996 |
| 12:82403002:T:C | L384P | 0.995 |
| 12:82438745:G:C | A478P | 0.995 |
| 12:82438746:C:A | A478D | 0.995 |
| 12:82477330:G:C | R566P | 0.995 |
| 12:82478965:T:C | F585L | 0.995 |
| 12:82478967:T:A | F585L | 0.995 |
| 12:82478967:T:G | F585L | 0.995 |
| 12:82389855:A:T | K155I | 0.994 |
| 12:82389864:A:T | E158V | 0.994 |
| 12:82389865:A:C | E158D | 0.994 |
| 12:82389865:A:T | E158D | 0.994 |
| 12:82398911:A:C | R216S | 0.994 |
| 12:82398911:A:T | R216S | 0.994 |
| 12:82403085:T:C | C412R | 0.994 |
| 12:82478987:G:T | R592I | 0.994 |
| 12:82389856:A:C | K155N | 0.993 |
| 12:82389856:A:T | K155N | 0.993 |
| 12:82398819:G:C | G186R | 0.993 |
| 12:82398826:T:C | L188P | 0.993 |
| 12:82403020:T:C | L390P | 0.993 |
| 12:82430980:C:A | A456E | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000083930 (12:82446260 C>A,T), RS1000091090 (12:82455086 C>T), RS1000115993 (12:82433538 A>G), RS1000130534 (12:82403628 A>G,T), RS1000136362 (12:82445941 G>A), RS1000195598 (12:82392423 A>G), RS1000211459 (12:82386728 A>C,G), RS1000236822 (12:82432680 C>A), RS1000250464 (12:82386157 G>A,C), RS1000279924 (12:82469954 T>C,G), RS1000281052 (12:82380275 T>C), RS1000321028 (12:82437505 T>G), RS1000327539 (12:82473392 A>C), RS1000345777 (12:82386354 T>C), RS1000384288 (12:82440002 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006417_3 | Plasma factor VII activating protease levels | 2.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 3 |
| Air Pollutants | increases abundance, decreases expression | 2 |
| Aflatoxin B1 | decreases expression, decreases methylation | 2 |
| Particulate Matter | decreases expression, increases abundance | 2 |
| aristolochic acid I | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Decitabine | affects expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Cisplatin | affects expression | 1 |
| Estradiol | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin M1 | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.